Expression of a hepatocyte membrane antigen during hepatocarcinogenesis and in the developing liver of the rat.
Changes in the expression of a cell membrane antigen during hepatocarcinogenesis and in the developing liver were analyzed by HAM.4, a monoclonal antibody (MAb) against a membrane glycoprotein of normal rat hepatocyte. Of the precancerous lesions observed during hepatocarcinogenesis induced by diethylnitrosamine, 2-acetylaminofluorene and partial hepatectomy, early neoplastic foci were uniformly stained by HAM.4. In contrast, some cells in the neoplastic nodules at the late stage did not express HAM.4 antigen on the cell surface. Of the cancer tissues, well-differentiated hepatocellular carcinomas were stained by HAM.4 whereas poorly differentiated carcinomas did not bind HAM.4 In developing rat liver, HAM.4 antigen was first expressed on fetal hepatocytes at the 18th day of gestation. It gradually increased until 4 weeks after birth when the intensity of the stain was almost the same as in adult rat liver. These results suggest that the expression of a membrane antigen defined by HAM.4 is closely associated with the differentiation of bile canalicular face and that HAM.4 might be useful in characterizing differentiation of cells during malignant transformation of hepatocytes.
D000818:Animals; D000954:Antigens, Surface / Q000032:analysis*; D006023:Glycoproteins / Q000032:analysis*; D008099:Liver / Q000196:embryology / Q000276:immunology*; D008114:Liver Neoplasms, Experimental / Q000276:immunology*; D008297:Male; D011230:Precancerous Conditions / Q000276:immunology; D051381:Rats; D011916:Rats, Inbred F344; D005723:gamma-Glutamyltransferase / Q000032:analysis
D000954:Antigens, Surface; D006023:Glycoproteins; D005723:gamma-Glutamyltransferase